Tilray Inc (NASDAQ:TLRY)
recently announced that it added Ireland the list of markets where it sells
its cannabis products, particularly its Good Manufacturing Practices
(GMP)-certified medical marijuana oils.
The company announced on Friday last week that it imported
its GMP-certified cannabis oils into the Ireland where they will be made
available throughout the European country. Tilray’s expansion into the country
is also courtesy of the Medical Cannabis Access Programme which was enacted by
Ireland’s Department of Health to help patients gain access to medical
“We’re proud to have the opportunity to provide patients in Ireland with access to Tilray’s standardized GMP-certified medical cannabis products,” stated Catherine Jacobson the VP of Medical and Regulatory Affairs at Tilray.
Jacobson also noted that the development represents an
important step forward not only for the company but also for medical marijuana
patients in Ireland. She also added that
Tilray is pleased about the growing number of countries that are making an
effort to boost access to medical marijuana.
Tilray is committed
to making the cannabis products available to patients in Ireland
Qualified patients will get access to Tilray’s imported
cannabis products via the Access Programme as soon as local regulators provide
distribution approvals. This is also great news for qualified patients because
it means they will access a consistent and legal supply of the products. Additionally, the company aims to provide
timely access to GMP-certified products, thus providing patients with even more
Authorized medical marijuana patients will access medical
marijuana products from Tilray within the second half of 2019. The products
will be made available through a network of Irish pharmacies. The company’s Managing
Director for Europe, Sascha Mielcarek stated that the company was pleased about
launching its products in Ireland. It is now the 13th country to
import Tilray products for sale in its market.
Tilray also plans to continue expanding its operations in
Europe and the rest of the world as part of its global expansion plan. These
efforts plus the fact that more countries are embracing its products means that
the company is gaining significant progress as and market share in its global